Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ)
CNY 80.33
(-2.26%)
CNY 80.33
(-2.26%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.02 Billion CNY | 13.51% |
| 2022 | 1.78 Billion CNY | 5.7% |
| 2021 | 1.68 Billion CNY | 74.68% |
| 2020 | 965.7 Million CNY | 13.3% |
| 2019 | 852.36 Million CNY | 20.31% |
| 2018 | 708.46 Million CNY | 4.73% |
| 2017 | 676.47 Million CNY | -6.23% |
| 2016 | 721.41 Million CNY | 10.83% |
| 2015 | 650.94 Million CNY | -2.98% |
| 2014 | 670.9 Million CNY | 18.28% |
| 2013 | 567.2 Million CNY | 35.69% |
| 2012 | 418.02 Million CNY | 56.05% |
| 2011 | 267.88 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 2.18 Billion CNY | 4.95% |
| 2024 Q1 | 2.12 Billion CNY | 4.92% |
| 2024 Q2 | 2.08 Billion CNY | -1.92% |
| 2023 Q3 | 1.91 Billion CNY | 2.44% |
| 2023 Q4 | 2.02 Billion CNY | 5.5% |
| 2023 FY | 2.02 Billion CNY | 13.51% |
| 2023 Q1 | 1.82 Billion CNY | 2.59% |
| 2023 Q2 | 1.87 Billion CNY | 2.38% |
| 2022 Q3 | 1.77 Billion CNY | 4.58% |
| 2022 Q2 | 1.69 Billion CNY | 0.6% |
| 2022 Q1 | 1.68 Billion CNY | -0.21% |
| 2022 Q4 | 1.78 Billion CNY | 0.67% |
| 2022 FY | 1.78 Billion CNY | 5.7% |
| 2021 Q2 | 1.08 Billion CNY | 4.16% |
| 2021 Q4 | 1.68 Billion CNY | 43.11% |
| 2021 Q1 | 1.04 Billion CNY | 8.26% |
| 2021 FY | 1.68 Billion CNY | 74.68% |
| 2021 Q3 | 1.17 Billion CNY | 8.24% |
| 2020 Q4 | 965.7 Million CNY | 4.03% |
| 2020 FY | 965.7 Million CNY | 13.3% |
| 2020 Q2 | 854.13 Million CNY | 8.14% |
| 2020 Q1 | 789.83 Million CNY | -7.34% |
| 2020 Q3 | 928.3 Million CNY | 8.68% |
| 2019 Q2 | 791.42 Million CNY | 11.21% |
| 2019 FY | 852.36 Million CNY | 20.31% |
| 2019 Q1 | 711.64 Million CNY | 0.45% |
| 2019 Q4 | 852.36 Million CNY | 2.93% |
| 2019 Q3 | 828.06 Million CNY | 4.63% |
| 2018 Q1 | 678.84 Million CNY | 0.35% |
| 2018 Q4 | 708.46 Million CNY | 1.31% |
| 2018 FY | 708.46 Million CNY | 4.73% |
| 2018 Q3 | 699.3 Million CNY | 2.23% |
| 2018 Q2 | 684.02 Million CNY | 0.76% |
| 2017 Q2 | 656.87 Million CNY | -1.42% |
| 2017 Q3 | 674.3 Million CNY | 2.65% |
| 2017 Q4 | 676.47 Million CNY | 0.32% |
| 2017 FY | 676.47 Million CNY | -6.23% |
| 2017 Q1 | 666.37 Million CNY | -7.63% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | 721.41 Million CNY | 10.83% |
| 2016 Q4 | 721.41 Million CNY | 11.81% |
| 2016 Q3 | 645.19 Million CNY | 0.09% |
| 2016 Q2 | 644.59 Million CNY | 0.0% |
| 2015 FY | 650.94 Million CNY | -2.98% |
| 2014 Q4 | 670.9 Million CNY | 2.08% |
| 2014 FY | 670.9 Million CNY | 18.28% |
| 2014 Q3 | 657.2 Million CNY | 0.0% |
| 2013 FY | 567.2 Million CNY | 35.69% |
| 2012 FY | 418.02 Million CNY | 56.05% |
| 2011 FY | 267.88 Million CNY | 0.0% |